http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022378766-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc1e74857262e51b02125ce47f6d705b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f1b0ca1d89799b191a8860e243dd94 |
| publicationDate | 2022-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022378766-A1 |
| titleOfInvention | Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxide |
| abstract | Some embodiments disclosed herein include a method for increasing an expression level of a gene. The methods include identifying a human subject having a decreased expression level of UCP3; and administering to the human subject an effective amount of a nitroxide antioxidant, whereby expression level of the gene is increased. |
| priorityDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.